<DOC>
	<DOCNO>NCT00805792</DOCNO>
	<brief_summary>This study involve treat patient suffer acute ischemic stroke medication donepezil ( Aricept ® ) . The hypothesis take donepezil ( FDA-approved treatment Alzheimer 's Disease ) first 90 day follow stroke enhances recovery .</brief_summary>
	<brief_title>Mayo Acute Stroke Trial Enhancing Recovery</brief_title>
	<detailed_description>We hypothesize donepezil ( 5 mg per day , titrate 10 mg per day tolerate ) enhance recovery follow stroke improve attention , learn memory thereby enhance rehabilitation . The null hypothesis probability favorable outcome among post-stroke donepezil user equal observe among similar participant exist National Institutes Neurological Disorders Stroke ( NINDS ) resource , Phase III clinical trial Tissue Plasminogen Activator ( tPA ) acute ischemic stroke . The NINDS tPA stroke trial use historical control data pilot trial reperfusion neuroprotection . The MASTER trial multicenter , single-arm NINDS Recominant tPA trial-controlled , modify 2-stage adaptive clinical trial set 2 tertiary care hospital United States . Participants men woman acute ( &lt; 24 hour onset symptom ) ischemic stroke . A favorable outcome define National Institutes Health Stroke Scale ( NIHSS ) value 0 1 90 day post-stroke .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Definite probable acute ischemic cerebrovascular syndrome ( AICS ) , define Kidwell et al ( Stroke . 2003 ; 34:29958 ) . Experimental treatment start within 24 hour onset symptom . Age ≥ 18 year . Ability willingness return followup visit . Willingness available informant know patient well participate informantbased questionnaire duration followup period . Living independent semiindependent live situation stroke . Fluent English stroke . Provides write informed consent . Near visual acuity least 20/200 least one eye . Auditory acuity least ability detect finger rub least one ear . Parkinson 's disease restless leg syndrome . Partial generalized seizure . No acute decompensated heart failure Routinely require daytime supplemental oxygen stroke ; study participant continuous positive air pressure ( CPAP ) obstructive sleep apnea remain eligible . Gastrointestinal genitourinary surgery within 1 month screening . Gastrointestinal bleeding . Syncope symptomatic bradycardia . Creatinine ≥ 3.5 mg/dL require dialysis . Peptic ulcer disease . Asthma . Tracheostomy endotracheal intubation . Taking donepezil acetylcholinesterase inhibitor screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Ischemic stroke</keyword>
	<keyword>treatment</keyword>
	<keyword>recovery</keyword>
	<keyword>donepezil</keyword>
	<keyword>Aricept</keyword>
</DOC>